Production (Stage)
Nexien BioPharma, Inc.
NXEN
$0.0145
$0.00552.63%
OTC PK
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -40.42% | 52.87% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -40.42% | 52.87% | |||
| Operating Income | 40.42% | -52.87% | |||
| Income Before Tax | 23.80% | -23.44% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 23.80% | -23.44% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 23.80% | -23.44% | |||
| EBIT | 40.42% | -52.87% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 33.33% | -20.00% | |||
| Normalized Basic EPS | 0.00% | 0.00% | |||
| EPS Diluted | 33.33% | -20.00% | |||
| Normalized Diluted EPS | 0.00% | 0.00% | |||
| Average Basic Shares Outstanding | 0.01% | 0.42% | |||
| Average Diluted Shares Outstanding | 0.01% | 0.42% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||